Skip To Main Content

Facts and Figures

Rankings

Biomedical engineering at Texas A&M University has been a degree-granting program since 1972 and has been ABET-accredited since 1977. The department's graduate program is ranked 18th among public institutions by U.S. News & World Report.
$28.4M research expenditures By U.S. News and World Report | American Society for Engineering Education

FY2024

30 tenure track faculty Faculty directory

Tenure track faculty on staff in Fall 2025.

Student Enrollment

Enrollment (Fall 2025)
Student Level Non-Distance Education Students1 In-State Distance Education Students1 THECB Totals1 Out-of-State Distance Education Students Total Enrollment of all Students
Undergraduate 508 508 508
Master's 69 69 69
Doctoral 125 125 125
Total Enrollment 702 0 702 0 702
Source: Office of Academic & Business Performance Analytics, Texas A&M University
1As reported to the Texas Higher Education Coordinating Board

Degrees Awarded

Degrees Awarded (Fall 2024, Spring 2025, Summer 2025)
Student Level Number of Students
Bachelor's 161
Master's 33
Doctoral 22
Total Degrees Awarded 216
Source: Office of Academic & Business Performance Analytics, Texas A&M University

Faculty

Our faculty members are involved in research from the macroscopic to the nanoscale in the areas of diagnostic and therapeutic systems, imaging systems, soft and hard tissue biomechanics, tissue characterizations, biomaterials used in the human body, orthopedic biomechanics, FDA regulatory practices, bioinstrumentation, measurement and analysis of human body signals, and analysis of the interaction between humans and medical devices. In addition, they have strong collaborations with medical and veterinary schools as well as various other departments throughout the university and around the world. 

Faculty (Fall 2025)
Tenure Status Number of Faculty
Tenured/Tenure-Track 30
Academic Professional Track 13
Total Faculty 43

Faculty Recognition

  • Eight Endowed Professorships
  • 29 editorships and editorial board memberships
  • 42 Fellow grades in professional societies
Our research has resulted in new patents, new companies and new economic activity. With increasing demands for quality medical devices, procedures and improved cost-effectiveness, we are positioned to lead the way in the development, testing and commercialization of products, systems and technologies.
  • $19M in external research funding (FY2021)
  • 90 patents filed (2019-2023)
  • 38 disclosures filed
  • 11 start-up companies created, including one exit through acquisition by Medtronic, Inc.
  • 102 Invention Disclosures submitted and 20 Patents issued (US and non-US combined)

Research Areas